Feasibility of Bone Marrow Mesenchymal Stem Cell-Mediated Synthetic Radiosensitive Promoter-Combined Sodium Iodide Symporter for Radiogenetic Ovarian Cancer Therapy

Shi, S; Li, F; Wu, LC; Zhang, LW; Liu, L

Shi, S (corresponding author), Fudan Univ, Obstet & Gynecol Hosp, Dept Gynecol, 128 Shenyang Rd, Shanghai 200090, Peoples R China.

HUMAN GENE THERAPY, ; ():

Abstract

Ovarian cancer is the most lethal gynecological cancer, most patients relapse within 12-24 months, and eventually die, especially platinum-resistant p......

Full Text Link